unknown
Stage
1
Investors
About
Acerta Pharma develops targeted cancer therapies, focusing on kinase inhibitors for the treatment of hematologic and solid tumor cancers.
Explore Acerta Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.